Wang, Chengran
Dong, Tianqi
Rong, Xin’ao
Yang, Yuce
Mou, Jianhui
Li, Jiaqi
Ge, Jianli
Mu, Xupeng
Jiang, Jinlan
Funding for this research was provided by:
the National Natural Science Foundation of China (82172230)
the Changchun Scientific and Technological Development Program (21ZGY29)
Life Spring AKY Pharmaceuticals (3R218FM83430)
the Jilin Scientific and Technological Development Program (20240205001YY)
the Jilin Health Service Capacity Improvement Program (2017F014)
Article History
Received: 1 October 2024
Accepted: 31 March 2025
First Online: 31 May 2025
Declarations
:
: The authors declare no competing interests.